Published by Josh White on 5th October 2023
(Sharecast News) - Cell engineering specialist MaxCyte revised its full-year guidance downwards on Thursday based on its preliminary third-quarter revenue.
URL: http://www.digitallook.com/dl/news/story/33817609/...